Target intelligence / Profile preview

RTCA antisense RNA 1 (RTCA-AS1)

Target
RTCA-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

RTCA antisense RNA 1 (RTCA-AS1) is a human long non-coding antisense RNA, identified for its marked positive correlation with chromatin-modifying protein 4 (CHMP4A), a component of the ESCRT-III complex involved in endosomal sorting and autophagy-related pathways[5]. As a lncRNA, RTCA-AS1 likely regulates the expression and function of nearby or overlapping protein-coding genes by antisense mechanisms, including chromatin remodeling and mRNA stability modulation, roles broadly established for antisense lncRNAs in gene regulation[6]. RTCA-AS1 has been associated through gene expression analysis with cancer-related regulatory networks but is not a conventional receptor, enzyme, or druggable protein target[5].\n\nNo known therapeutics, biomarkers, or safety concerns have been documented for RTCA-AS1, and it is not considered an established therapeutic target at this time.

02

Mechanism of action

Not applicable; as RTCA-AS1 is not directly targeted by drugs, mechanisms relate to its natural gene regulatory function (e.g., antisense RNA regulatory effects, chromatin modification through interaction partners)[5][6]

03

Biological functions

Regulation of gene expression (by antisense pairing or co-expression)Chromatin modification/regulation (via co-expression with chromatin-modifying proteins)Potential modulation of autophagy-related pathways (based on correlation with CHMP4A, involved in endosomal and autophagic pathways)
04

Disease associations

Cancer (specifically, correlative studies in ovarian cancer and possibly others via interaction with chromatin-modifying protein 4 - CHMP4A)Other (potentially autophagy-related diseases based on its co-expression with autophagy-associated genes)

Beyond the preview

Go deeper on RTCA antisense RNA 1 (RTCA-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RTCA antisense RNA 1 (RTCA-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call